Literature DB >> 15331174

No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.

Robert Grützmann1, Christopher McFaul, Detlef K Bartsch, Mercedes Sina-Frey, Harald Rieder, Rainer Koch, Emma McCarthy, William Greenhalf, John P Neoptolemos, Hans Detlev Saeger, Christian Pilarsky.   

Abstract

Familial pancreatic cancer (FPC) (approximately 3% of all cases) has not been linked to defects in any specific gene. Germline inactivation of the gene LKB1/STK11 have been shown to cause Peutz-Jeghers syndrome (PJS) associated with a approximately 100-fold higher risk for the development of pancreatic cancer. We have analysed 39 index patients from European FPC families for mutations of LKB1/STK11 by sequencing of their DNA. No germline mutation was found within the complete coding region. Therefore, our results indicate that LKB1/STK11 is not altered in the germline of patients with hereditary pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331174     DOI: 10.1016/j.canlet.2004.06.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

Review 3.  [Prophylactic pancreas surgery].

Authors:  P Langer; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 4.  Early detection of pancreatic cancer.

Authors:  Stephen P Pereira; Lucy Oldfield; Alexander Ney; Phil A Hart; Margaret G Keane; Stephen J Pandol; Debiao Li; William Greenhalf; Christie Y Jeon; Eugene J Koay; Christopher V Almario; Christopher Halloran; Anne Marie Lennon; Eithne Costello
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-02

5.  German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.

Authors:  Ralph Schneider; Emily P Slater; Mercede Sina; Nils Habbe; Volker Fendrich; Elvira Matthäi; Peter Langer; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

6.  Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Authors:  Emily P Slater; Peter Langer; Volker Fendrich; Nils Habbe; Brunhilde Chaloupka; Elvira Matthäi; Mercedes Sina; Stephan A Hahn; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 7.  [Hereditary pancreatic cancer].

Authors:  N Habbe; P Langer; D K Bartsch
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 8.  Risk factors and therapeutic targets in pancreatic cancer.

Authors:  Sonja Maria Wörmann; Hana Algül
Journal:  Front Oncol       Date:  2013-11-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.